286 related articles for article (PubMed ID: 25365423)
1. Identification of molecular pathways facilitating glioma cell invasion in situ.
Nevo I; Woolard K; Cam M; Li A; Webster JD; Kotliarov Y; Kim HS; Ahn S; Walling J; Kotliarova S; Belova G; Song H; Bailey R; Zhang W; Fine HA
PLoS One; 2014; 9(11):e111783. PubMed ID: 25365423
[TBL] [Abstract][Full Text] [Related]
2. RTVP-1 promotes mesenchymal transformation of glioma via a STAT-3/IL-6-dependent positive feedback loop.
Giladi ND; Ziv-Av A; Lee HK; Finniss S; Cazacu S; Xiang C; Waldman Ben-Asher H; deCarvalho A; Mikkelsen T; Poisson L; Brodie C
Oncotarget; 2015 Sep; 6(26):22680-97. PubMed ID: 26267319
[TBL] [Abstract][Full Text] [Related]
3. BEHAB (brain enriched hyaluronan binding) is expressed in surgical samples of glioma and in intracranial grafts of invasive glioma cell lines.
Jaworski DM; Kelly GM; Piepmeier JM; Hockfield S
Cancer Res; 1996 May; 56(10):2293-8. PubMed ID: 8625302
[TBL] [Abstract][Full Text] [Related]
4. Pathological features of highly invasive glioma stem cells in a mouse xenograft model.
Sadahiro H; Yoshikawa K; Ideguchi M; Kajiwara K; Ishii A; Ikeda E; Owada Y; Yasumoto Y; Suzuki M
Brain Tumor Pathol; 2014 Apr; 31(2):77-84. PubMed ID: 23670138
[TBL] [Abstract][Full Text] [Related]
5. A novel drug conjugate, NEO212, targeting proneural and mesenchymal subtypes of patient-derived glioma cancer stem cells.
Jhaveri N; Agasse F; Armstrong D; Peng L; Commins D; Wang W; Rosenstein-Sisson R; Vaikari VP; Santiago SV; Santos T; Chen L; Schönthal AH; Chen TC; Hofman FM
Cancer Lett; 2016 Feb; 371(2):240-50. PubMed ID: 26683773
[TBL] [Abstract][Full Text] [Related]
6. Identification and functional validation of CDH11, PCSK6 and SH3GL3 as novel glioma invasion-associated candidate genes.
Delic S; Lottmann N; Jetschke K; Reifenberger G; Riemenschneider MJ
Neuropathol Appl Neurobiol; 2012 Apr; 38(2):201-12. PubMed ID: 21722156
[TBL] [Abstract][Full Text] [Related]
7. Targeting neuronal activity-regulated neuroligin-3 dependency in high-grade glioma.
Venkatesh HS; Tam LT; Woo PJ; Lennon J; Nagaraja S; Gillespie SM; Ni J; Duveau DY; Morris PJ; Zhao JJ; Thomas CJ; Monje M
Nature; 2017 Sep; 549(7673):533-537. PubMed ID: 28959975
[TBL] [Abstract][Full Text] [Related]
8. Glioma stem cells are more aggressive in recurrent tumors with malignant progression than in the primary tumor, and both can be maintained long-term in vitro.
Huang Q; Zhang QB; Dong J; Wu YY; Shen YT; Zhao YD; Zhu YD; Diao Y; Wang AD; Lan Q
BMC Cancer; 2008 Oct; 8():304. PubMed ID: 18940013
[TBL] [Abstract][Full Text] [Related]
9. Glioma initiating cells contribute to malignant transformation of host glial cells during tumor tissue remodeling via PDGF signaling.
Chen Y; Wang Z; Dai X; Fei X; Shen Y; Zhang M; Wang A; Li X; Wang Z; Huang Q; Dong J
Cancer Lett; 2015 Sep; 365(2):174-81. PubMed ID: 26049020
[TBL] [Abstract][Full Text] [Related]
10. Gab2 expression in glioma and its implications for tumor invasion.
Shi L; Sun X; Zhang J; Zhao C; Li H; Liu Z; Fang C; Wang X; Zhao C; Zhang X; Zhou F; Lu S; Luo R; Zhang B
Acta Oncol; 2013 Nov; 52(8):1739-50. PubMed ID: 23231021
[TBL] [Abstract][Full Text] [Related]
11. MicroRNA-218 inhibits glioma invasion, migration, proliferation, and cancer stem-like cell self-renewal by targeting the polycomb group gene Bmi1.
Tu Y; Gao X; Li G; Fu H; Cui D; Liu H; Jin W; Zhang Y
Cancer Res; 2013 Oct; 73(19):6046-55. PubMed ID: 23950210
[TBL] [Abstract][Full Text] [Related]
12. Downregulation of miR-95-3p inhibits proliferation, and invasion promoting apoptosis of glioma cells by targeting CELF2.
Fan B; Jiao BH; Fan FS; Lu SK; Song J; Guo CY; Yang JK; Yang L
Int J Oncol; 2015 Sep; 47(3):1025-33. PubMed ID: 26165303
[TBL] [Abstract][Full Text] [Related]
13. Glioma progression through the prism of heat shock protein mediated extracellular matrix remodeling and epithelial to mesenchymal transition.
Rajesh Y; Biswas A; Mandal M
Exp Cell Res; 2017 Oct; 359(2):299-311. PubMed ID: 28844885
[TBL] [Abstract][Full Text] [Related]
14. KITENIN promotes glioma invasiveness and progression, associated with the induction of EMT and stemness markers.
Lee KH; Ahn EJ; Oh SJ; Kim O; Joo YE; Bae JA; Yoon S; Ryu HH; Jung S; Kim KK; Lee JH; Moon KS
Oncotarget; 2015 Feb; 6(5):3240-53. PubMed ID: 25605251
[TBL] [Abstract][Full Text] [Related]
15. NKAP alters tumor immune microenvironment and promotes glioma growth via Notch1 signaling.
Gu G; Gao T; Zhang L; Chen X; Pang Q; Wang Y; Wang D; Li J; Liu Q
J Exp Clin Cancer Res; 2019 Jul; 38(1):291. PubMed ID: 31277684
[TBL] [Abstract][Full Text] [Related]
16. Microregional extracellular matrix heterogeneity in brain modulates glioma cell invasion.
Bellail AC; Hunter SB; Brat DJ; Tan C; Van Meir EG
Int J Biochem Cell Biol; 2004 Jun; 36(6):1046-69. PubMed ID: 15094120
[TBL] [Abstract][Full Text] [Related]
17. MiR-200a impairs glioma cell growth, migration, and invasion by targeting SIM2-s.
Su Y; He Q; Deng L; Wang J; Liu Q; Wang D; Huang Q; Li G
Neuroreport; 2014 Jan; 25(1):12-7. PubMed ID: 24162743
[TBL] [Abstract][Full Text] [Related]
18. Fibulin-3 is uniquely upregulated in malignant gliomas and promotes tumor cell motility and invasion.
Hu B; Thirtamara-Rajamani KK; Sim H; Viapiano MS
Mol Cancer Res; 2009 Nov; 7(11):1756-70. PubMed ID: 19887559
[TBL] [Abstract][Full Text] [Related]
19. miR-656 inhibits glioma tumorigenesis through repression of BMPR1A.
Guo M; Jiang Z; Zhang X; Lu D; Ha AD; Sun J; Du W; Wu Z; Hu L; Khadarian K; Shen J; Lin Z
Carcinogenesis; 2014 Aug; 35(8):1698-706. PubMed ID: 24480809
[TBL] [Abstract][Full Text] [Related]
20. Molecular Pathways Mediating Metastases to the Brain via Epithelial-to-Mesenchymal Transition: Genes, Proteins, and Functional Analysis.
Jeevan DS; Cooper JB; Braun A; Murali R; Jhanwar-Uniyal M
Anticancer Res; 2016 Feb; 36(2):523-32. PubMed ID: 26851006
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
